Lactose India Ltd Secures NCLT Approval for Vitanosh Ingredients Merger

Lactose (India) Ltd's manufacturing capacity to increase to 15,000 MT/annum; new products to be added.

Reader Takeaway: Merger offers capacity expansion and broader market access, but contingent on regulatory compliance and share issuance.

What just happened

The National Company Law Tribunal (NCLT), Ahmedabad Bench, has sanctioned the Scheme of Amalgamation between Lactose (India) Ltd (Transferee Company) and Vitanosh Ingredients Pvt Ltd (Transferor Company). The order was passed on August 5, 2026, with the amalgamation deemed effective from the Appointed Date of October 1, 2024.

Why this matters

This approval is a significant step for Lactose (India) Ltd as it paves the way for operational integration and synergistic benefits. The company anticipates a substantial increase in its manufacturing capacity and an expansion of its product offerings, which could lead to improved market positioning and financial performance.

The backstory

Lactose (India) Ltd, the transferee company, is involved in the business of manufacturing and marketing various lactose-based products. Vitanosh Ingredients Pvt Ltd is the transferor entity. The scheme of amalgamation was proposed to consolidate operations and achieve economies of scale.

What changes now

Following the NCLT's sanction, Lactose (India) Ltd will issue new equity shares to the shareholders of Vitanosh Ingredients Pvt Ltd at a ratio of 0.7946 equity shares of Lactose (India) Ltd for every 1 equity share held in Vitanosh Ingredients. The company is also directed to lodge the order with the Superintendent of Stamps and comply with accounting treatment as per Section 133 of the Companies Act, 2013.

Risks to watch

While the merger is approved, potential tax liabilities remain with the Income Tax Department, and the transferee company is liable for statutory obligations. Compliance with SEBI regulations and the successful issuance of new shares are critical next steps.

Peer comparison

As Lactose (India) Ltd focuses on lactose and related derivatives, its peers could include other dairy ingredient manufacturers and specialty chemical companies. The increased capacity and expanded product range post-merger could allow it to compete more effectively in the market.

Context metrics (time-bound)

The amalgamation's effective date is October 1, 2024. The NCLT order date is August 5, 2026, and the company received the order on August 20, 2026. The current manufacturing capacity is 10,000 MT/annum, projected to increase to 15,000 MT/annum post-merger.

What to track next

Investors should monitor the filing of the certified NCLT order with the Registrar of Companies and the announcement of the record date for the allotment of new equity shares. Tracking the integration progress and realization of expected synergies will be crucial.